Skip to content
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
Category: Regulatory/FDA
10/25/2021
FDA Draft Guidance for Real-world Data: Documentation of Data Approach Is Key
Learn More
10/11/2021
FDA Issues BsUFA Commitment Letter, to Hold Public Meeting Nov. 2
Learn More
10/04/2021
Comment Now on FDA Draft Guidance on Use of EHR, Claims Data as RWD
Learn More
09/27/2021
FDA, HRA Starting to Address Trial Investigator Result Reporting Lapses
Learn More
09/20/2021
BMJ Study: Accelerated Approval Drugs Retain Status Despite Lack of Benefit
Learn More
08/30/2021
OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links
Learn More
08/10/2021
FDA Accepting Comment on Burden of Drug Advertising, HCEI Communications Disclosures
Learn More
07/29/2021
OPDP To Study Impact of Exhibit Booth Materials, Medical Conference Conversations on HCPs
Learn More
07/26/2021
Amgen Gets OPDP Untitled Letter for Claims about Neulasta Onpro vs. PFS Delivery
Learn More
«
Page
1
…
Page
4
Page
5
Page
6
Page
7
Page
8
…
Page
37
»